Order Article Reprints

Yu P, Shang C, Liu Z, Li Y, He T, Xue Y, Lin J, Li Y, Wu Y, Liu T, et al. High Co-Expression of GPAT4 and SLC7A11 as a Predictor of Platinum Resistance and Poor Prognosis in Patients with Epithelial Ovarian Cancer. Biomedicines. 2025; 13(7):1664. https://doi.org/10.3390/biomedicines13071664

Yu, Ping, Chunliang Shang, Zhongyu Liu, Yuan Li, Tianhui He, Yuan Xue, Jian Lin, Yuan Li, Yu Wu, Tong Liu, and et al. 2025. "High Co-Expression of GPAT4 and SLC7A11 as a Predictor of Platinum Resistance and Poor Prognosis in Patients with Epithelial Ovarian Cancer" Biomedicines 13, no. 7: 1664. https://doi.org/10.3390/biomedicines13071664

Yu, P., Shang, C., Liu, Z., Li, Y., He, T., Xue, Y., Lin, J., Li, Y., Wu, Y., Liu, T., & Guo, H. (2025). High Co-Expression of GPAT4 and SLC7A11 as a Predictor of Platinum Resistance and Poor Prognosis in Patients with Epithelial Ovarian Cancer. Biomedicines, 13(7), 1664. https://doi.org/10.3390/biomedicines13071664